GESTIÓN EN SALUD PÚBLICA: Improving Access to High-Value, High-Cost Medicines: The Use of Subscription Models to Treat Hepatitis C Using Direct-Acting Antivirals in the United States - PubMed

miércoles, 8 de febrero de 2023

Improving Access to High-Value, High-Cost Medicines: The Use of Subscription Models to Treat Hepatitis C Using Direct-Acting Antivirals in the United States - PubMed

Improving Access to High-Value, High-Cost Medicines: The Use of Subscription Models to Treat Hepatitis C Using Direct-Acting Antivirals in the United States - PubMed

No hay comentarios:

Publicar un comentario

Suscribirse a: Enviar comentarios (Atom)